BMA, CRDO and APPS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 7, 2026.
Banco Macro S.A. (BMA) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the bank shows a 63.4% growth in net interest income, the 238.8 billion ARS in loan loss provisions and high valuation metrics like a 25.59 P/E TTM suggest significant downside risk in a hyperinflationary environment.
Banco Macro S.A. (BMA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Banco Macro S.A. (BMA) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 27, 2026 | $1.73vs $1.42+21.8% | $1.2Bvs $838M+47.0% |
| Q1 2026 | Feb 26, 2026 | $1.98vs $1.38+43.5% | $898Mvs $759M+18.4% |
| Q1 2026 | Feb 25, 2026 | $1.98vs $1.38+43.5% | $898Mvs $759M+18.4% |
| Q4 2025 | Nov 26, 2025 | $0.39vs $0.67-158.2% | $1.0Bvs $732M+38.2% |
Recent stock market news and headlines for Banco Macro S.A. (BMA)
BMA, CRDO and APPS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 7, 2026.
Banco Macro (BMA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Investors interested in Banks - Foreign stocks are likely familiar with Banco Macro (BMA) and National Australia Bank Ltd. (NABZY). But which of these two companies is the best option for those looking for undervalued stocks?

The mean of analysts' price targets for Banco Macro (BMA) points to a 29.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Does Banco Macro (BMA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Key metrics vs top competitors for Banco Macro S.A. (BMA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $91.65 | $5.86B | 25.80 | -10.04% | 5.8% | 7.26% | — | |
| $51.10 | $8.21B | 53.42 | 16.86% | 0.65% | 1.15% | — | |
| $9.25 | $809.8M | -21.06 | 13.71% | -2.23% | -3.27% | — | |
| $20.08 | $4.1B | 19.35 | 8.34% | 4.88% | 8.96% | — | |
| $14.86 | $2.23B | 8.23 | 73.24% | 34.18% | 27.39% | — | |
| $8.23 | $90.71B | 10.76 | 18.03% | 11.91% | 20.77% | — |
Banco Macro S.A. (BMA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when BMA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Banco Macro S.A. (BMA) stock FAQ — growth, dividends, profitability & financials explained
Banco Macro S.A. (BMA) saw revenue decline by 10.0% over the past year.
Yes, Banco Macro S.A. (BMA) is profitable, generating $371.55B in net income for fiscal year 2025 (5.8% net margin).
Banco Macro S.A. (BMA) has a return on equity (ROE) of 7.3%. This is below average, suggesting room for improvement.
Banco Macro S.A. (BMA) has a net interest margin (NIM) of 15.4%. This indicates healthy earnings from lending activities.
Banco Macro S.A. (BMA) has an efficiency ratio of 40.3%. This is excellent, indicating strong cost control.